Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$32.09 - $37.51 $43,481 - $50,826
1,355 Added 4.92%
28,912 $959,000
Q2 2023

Aug 03, 2023

BUY
$36.12 - $41.79 $995,358 - $1.15 Million
27,557 New
27,557 $1.01 Million
Q1 2023

Apr 19, 2023

SELL
$39.39 - $51.28 $6,066 - $7,897
-154 Reduced 0.55%
27,953 $1.14 Million
Q4 2022

Feb 16, 2023

SELL
$41.75 - $54.5 $22,795 - $29,757
-546 Reduced 1.91%
28,107 $1.44 Million
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $27,656 - $33,761
-632 Reduced 2.16%
28,653 $1.25 Million
Q2 2022

Aug 05, 2022

BUY
$46.53 - $55.17 $7,584 - $8,992
163 Added 0.56%
29,285 $1.54 Million
Q1 2022

May 06, 2022

BUY
$45.75 - $56.69 $92,781 - $114,967
2,028 Added 7.49%
29,122 $1.51 Million
Q4 2021

Feb 02, 2022

BUY
$41.32 - $61.25 $3,016 - $4,471
73 Added 0.27%
27,094 $1.6 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $6,005 - $7,714
153 Added 0.57%
27,021 $1.16 Million
Q2 2021

Jul 23, 2021

BUY
$35.91 - $40.68 $116,527 - $132,006
3,245 Added 13.74%
26,868 $1.05 Million
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $290,994 - $328,183
8,689 Added 58.18%
23,623 $856,000
Q4 2020

Jan 20, 2021

SELL
$33.47 - $42.56 $418,676 - $532,383
-12,509 Reduced 45.58%
14,934 $550,000
Q3 2020

Oct 19, 2020

BUY
$31.75 - $37.25 $871,315 - $1.02 Million
27,443 New
27,443 $1.01 Million
Q1 2020

May 13, 2020

SELL
$27.03 - $38.62 $201,941 - $288,530
-7,471 Closed
0 $0
Q4 2019

Feb 25, 2020

BUY
$32.92 - $37.36 $245,945 - $279,116
7,471 New
7,471 $293,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $166B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Maltin Wealth Management, Inc. Portfolio

Follow Maltin Wealth Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maltin Wealth Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maltin Wealth Management, Inc. with notifications on news.